Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Income (2016 - 2025)

Historic Net Income for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $153.7 million.

  • Neurocrine Biosciences' Net Income rose 4907.86% to $153.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $478.6 million, marking a year-over-year increase of 4022.85%. This contributed to the annual value of $478.6 million for FY2025, which is 4022.85% up from last year.
  • Neurocrine Biosciences' Net Income amounted to $153.7 million in Q4 2025, which was up 4907.86% from $209.5 million recorded in Q3 2025.
  • Over the past 5 years, Neurocrine Biosciences' Net Income peaked at $209.5 million during Q3 2025, and registered a low of -$76.6 million during Q1 2023.
  • In the last 4 years, Neurocrine Biosciences' Net Income had a median value of $83.1 million in 2023 and averaged $77.8 million.
  • Its Net Income has fluctuated over the past 5 years, first skyrocketed by 15665.8% in 2024, then plummeted by 8179.72% in 2025.
  • Neurocrine Biosciences' Net Income (Quarter) stood at $22.5 million in 2021, then soared by 556.44% to $147.7 million in 2023, then crashed by 30.2% to $103.1 million in 2024, then surged by 49.08% to $153.7 million in 2025.
  • Its Net Income was $153.7 million in Q4 2025, compared to $209.5 million in Q3 2025 and $107.5 million in Q2 2025.